enVVeno Medical (NVNO) Net Cash Flow (2017 - 2026)

enVVeno Medical's Net Cash Flow history runs 10 years deep, the most recent figure standing at -$468000.0 for Q1 2026.

• In Q1 2026, Net Cash Flow fell 139.56% year-over-year to -$468000.0; the TTM figure through Mar 2026 stood at -$581000.0 (down 193.26% YoY), while the FY2025 annual figure was $1.3 million, up 170.26% from the prior year.
• Net Cash Flow was -$468000.0 for Q1 2026 at enVVeno Medical, down from $1.5 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $15.5 million in Q3 2024 to a low of -$42.3 million in Q2 2022.
• Historically, Net Cash Flow has averaged -$4.6 million across 5 years, with a median of -$741000.0 in 2025.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow plunged 1733.55% in 2023, then jumped 6596.12% in 2024.
• A 5-year view of Net Cash Flow shows it stood at $1.7 million in 2022, then slumped by 1733.55% to -$27.1 million in 2023, then soared by 40.4% to -$16.2 million in 2024, then jumped by 109.41% to $1.5 million in 2025, then plunged by 130.77% to -$468000.0 in 2026.
• The last three Net Cash Flow figures came in at -$468000.0 (Q1 2026), $1.5 million (Q4 2025), and -$741000.0 (Q3 2025), per Business Quant data.